RMTI

Rockwell Medical, Inc. - Common Stock (RMTI)

About Rockwell Medical, Inc. - Common Stock (RMTI)

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini on October 25, 1996 and is headquartered in Wixom, MI.

Details

Daily high

$1.15

Daily low

$1.03

Price at open

52 Week High

$5.15

52 Week Low

$0.78

Market cap

37.9M

Dividend yield

0.00%

Volume

150

Avg. volume

476,508

P/E ratio

-77.62

Rockwell Medical, Inc. - Common Stock News